Search research articles
Contact Us
Filters
Showing results (241-250 of 329) with videos related to
Page
of 33
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 17, 2019
Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging study
Oliver D Howes, Ilaria Bonoldi, Robert A McCutcheon, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 8, 2026
Associations between glutamate and cerebral blood flow in treatment-resistant schizophrenia during clozapine treatment
Junyu Sun, Fernando Zelaya, Kyra-Verena Sendt, et al.
JAMA Psychiatry
|
August 13, 2025
Dopamine and Mood in Psychotic Disorders: An 18F-DOPA PET Study
Sameer Jauhar, Robert A McCutcheon, Matthew M Nour, et al.
Biological Psychiatry
|
June 17, 2023
Synaptic Terminal Density Early in the Course of Schizophrenia: An In Vivo UCB-J Positron Emission Tomographic Imaging Study of SV2A
Ellis Chika Onwordi, Thomas Whitehurst, Ekaterina Shatalina, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
February 26, 2025
Mitochondria and Cognition: An [<sup>18</sup>F]BCPP-EF Positron Emission Tomography Study of Mitochondrial Complex I Levels and Brain Activation During Task Switching
Ekaterina Shatalina, Thomas Whitehurst, Ellis Chika Onwordi, et al.
Nature. Mental Health
|
April 10, 2023
Predicting treatment resistance from first-episode psychosis using routinely collected clinical information
Emanuele F Osimo, Benjamin I Perry, Pavan Mallikarjun, et al.
Molecular Psychiatry
|
July 19, 2025
Effects of antipsychotics on human cognitive function: causal evidence from healthy volunteers following sustained D2/D3 antagonism, D2/D3 partial agonism and placebo
Martin Osugo, Uzma Zahid, Pierluigi Selvaggi, et al.
EJNMMI Research
|
April 17, 2024
Mitochondrial complex I density is associated with IQ and cognition in cognitively healthy adults: an in vivo [<sup>18</sup>F]BCPP-EF PET study
Ekaterina Shatalina, Thomas S Whitehurst, Ellis Chika Onwordi, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
February 22, 2020
Variability in Action Selection Relates to Striatal Dopamine 2/3 Receptor Availability in Humans: A PET Neuroimaging Study Using Reinforcement Learning and Active Inference Models
Rick A Adams, Michael Moutoussis, Matthew M Nour, et al.
Biological Psychiatry
|
July 20, 2020
Meta-analysis of the Glial Marker TSPO in Psychosis Revisited: Reconciling Inconclusive Findings of Patient-Control Differences
Pontus Plavén-Sigray, Granville J Matheson, Jennifer M Coughlin, et al.
Page
of 33
Search research articles
Search
Showing results (241-250 of 329) with videos related to
Sort By:
Page
of 33
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 17, 2019
Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging study
Oliver D Howes, Ilaria Bonoldi, Robert A McCutcheon, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 8, 2026
Associations between glutamate and cerebral blood flow in treatment-resistant schizophrenia during clozapine treatment
Junyu Sun, Fernando Zelaya, Kyra-Verena Sendt, et al.
JAMA Psychiatry
|
August 13, 2025
Dopamine and Mood in Psychotic Disorders: An 18F-DOPA PET Study
Sameer Jauhar, Robert A McCutcheon, Matthew M Nour, et al.
Biological Psychiatry
|
June 17, 2023
Synaptic Terminal Density Early in the Course of Schizophrenia: An In Vivo UCB-J Positron Emission Tomographic Imaging Study of SV2A
Ellis Chika Onwordi, Thomas Whitehurst, Ekaterina Shatalina, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
February 26, 2025
Mitochondria and Cognition: An [<sup>18</sup>F]BCPP-EF Positron Emission Tomography Study of Mitochondrial Complex I Levels and Brain Activation During Task Switching
Ekaterina Shatalina, Thomas Whitehurst, Ellis Chika Onwordi, et al.
Nature. Mental Health
|
April 10, 2023
Predicting treatment resistance from first-episode psychosis using routinely collected clinical information
Emanuele F Osimo, Benjamin I Perry, Pavan Mallikarjun, et al.
Molecular Psychiatry
|
July 19, 2025
Effects of antipsychotics on human cognitive function: causal evidence from healthy volunteers following sustained D2/D3 antagonism, D2/D3 partial agonism and placebo
Martin Osugo, Uzma Zahid, Pierluigi Selvaggi, et al.
EJNMMI Research
|
April 17, 2024
Mitochondrial complex I density is associated with IQ and cognition in cognitively healthy adults: an in vivo [<sup>18</sup>F]BCPP-EF PET study
Ekaterina Shatalina, Thomas S Whitehurst, Ellis Chika Onwordi, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
February 22, 2020
Variability in Action Selection Relates to Striatal Dopamine 2/3 Receptor Availability in Humans: A PET Neuroimaging Study Using Reinforcement Learning and Active Inference Models
Rick A Adams, Michael Moutoussis, Matthew M Nour, et al.
Biological Psychiatry
|
July 20, 2020
Meta-analysis of the Glial Marker TSPO in Psychosis Revisited: Reconciling Inconclusive Findings of Patient-Control Differences
Pontus Plavén-Sigray, Granville J Matheson, Jennifer M Coughlin, et al.
Page
of 33